Acumen Stock Insiders

ABOS
 Stock
  

USD 5.60  0.22  3.78%   

Acumen Pharmaceuticals employes about 14 people. The company is managed by 10 executives with total tenure of roughly 33 years, averaging almost 3.0 years of service per executive having 1.4 employees per reported executive. Discussion of Acumen Pharmaceuticals management performance can provide insight into the enterprise performance. Note, employee sentiment is becoming a valuable factor that investors use to determine the amount of risk that may be associated with Acumen Pharmaceuticals future performance.
Please continue to Trending Equities.

Acumen Pharmaceuticals Management Team Effectiveness

Acumen Pharmaceuticals has return on total asset (ROA) of (0.1124) % which means that it has lost $0.1124 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (0.1783) %, meaning that it created substantial loss on money invested by shareholders. Acumen Pharmaceuticals management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities.

Acumen Pharmaceuticals Workforce Comparison

Acumen Pharmaceuticals is rated second in number of employees category among related companies. The total workforce of Biotechnology industry is presently estimated at about 36.0. Acumen Pharmaceuticals totals roughly 14.0 in number of employees claiming about 39% of stocks in Biotechnology industry.

Acumen Pharmaceuticals Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Acumen Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Acumen Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Acumen Pharmaceuticals insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Acumen Pharmaceuticals Benchmark Summation

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Highest value over a specified period line plots max value of Acumen Pharmaceuticals price series.
.

Acumen Pharmaceuticals Notable Stakeholders

An Acumen Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Acumen Pharmaceuticals often face trade-offs trying to please all of them. Acumen Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Acumen Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Robyn MA - Mang CommunicationsProfile
Julie Bockenstette - Ex HRProfile
Daniel MBA - Pres CEOProfile
Janice Hitchcock - VP AffairsProfile
Russell MS - Chief OfficerProfile
JD Esq - Chief OfficerProfile
Siew MS - Assistant OperationsProfile
Matt Zuga - Chief CFOProfile
Eric MD - Chief OfficerProfile
Liean MS - VP CMCProfile

About Acumen Pharmaceuticals Management Performance

The success or failure of an entity such as Acumen Pharmaceuticals often depends on how effective the management is. Acumen Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Acumen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Acumen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimers disease. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia. Acumen Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 14 people.
The data published in Acumen Pharmaceuticals' official financial statements usually reflect Acumen Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Acumen Pharmaceuticals. For example, before you start analyzing numbers published by Acumen accountants, it's critical to develop an understanding of what Acumen Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Acumen Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Acumen Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Acumen Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Acumen Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Acumen Pharmaceuticals' management to manipulate its earnings.

Acumen Pharmaceuticals Workforce Analysis

Traditionally, organizations such as Acumen Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Acumen Pharmaceuticals within its industry.

Acumen Pharmaceuticals Manpower Efficiency

Return on Acumen Pharmaceuticals Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee7.2 M
Net Loss Per Executive10.1 M
Please continue to Trending Equities. You can also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for analysis

When running Acumen Pharmaceuticals price analysis, check to measure Acumen Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acumen Pharmaceuticals is operating at the current time. Most of Acumen Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acumen Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Acumen Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acumen Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Is Acumen Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acumen Pharmaceuticals. If investors know Acumen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acumen Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
229.2 M
Return On Assets
(0.11) 
Return On Equity
(0.18) 
The market value of Acumen Pharmaceuticals is measured differently than its book value, which is the value of Acumen that is recorded on the company's balance sheet. Investors also form their own opinion of Acumen Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Acumen Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acumen Pharmaceuticals' market value can be influenced by many factors that don't directly affect Acumen Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Acumen Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Acumen Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acumen Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.